A previous investigation indicated that the purified anthocyanin from Lycium ruthenicum showcased ameliorative effect on atherosclerosis in rats through synergistic modulation of the gut microbiota and NF-κB/SREBP-2 pathways (Luo et al. 2019). The gene discussed is SREBF2; the disease is atherosclerosis.